134 related articles for article (PubMed ID: 8210836)
1. DNA flow cytometry: an update of its use in assessing prognosis for transitional cell cancer of the bladder.
Norming U
Semin Urol; 1993 Aug; 11(3):154-63. PubMed ID: 8210836
[No Abstract] [Full Text] [Related]
2. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
Miao T; Wang Z; Sang N; Xiong R; Cao S
Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer.
Ito M; Habuchi T; Watanabe J; Higashi S; Nishiyama H; Wang L; Tsuchiya N; Kamoto T; Ogawa O
Urology; 2004 Jul; 64(1):74-8. PubMed ID: 15245939
[TBL] [Abstract][Full Text] [Related]
4. Natural history of superficial bladder cancer. Prognostic features and long-term disease course.
Heney NM
Urol Clin North Am; 1992 Aug; 19(3):429-33. PubMed ID: 1636228
[TBL] [Abstract][Full Text] [Related]
5. Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident.
Yamamoto S; Romanenko A; Wei M; Masuda C; Zaparin W; Vinnichenko W; Vozianov A; Lee CC; Morimura K; Wanibuchi H; Tada M; Fukushima S
Cancer Res; 1999 Aug; 59(15):3606-9. PubMed ID: 10446970
[TBL] [Abstract][Full Text] [Related]
6. [Significance and application of DNA ploidy of bladder cancer cells in studying the malignancy of tumors].
Cao S
Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):143-5. PubMed ID: 2163740
[No Abstract] [Full Text] [Related]
7. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
[TBL] [Abstract][Full Text] [Related]
8. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer.
Bittard H; Lamy B; Billery C
J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer.
Pycha A; Mian C; Haitel A; Hofbauer J; Wiener H; Marberger M
J Urol; 1997 Jun; 157(6):2116-9. PubMed ID: 9146595
[TBL] [Abstract][Full Text] [Related]
11. DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality.
Baak JP; Bol MG; van Diermen B; Janssen EA; Buhr-Wildhagen SB; Mestad O; Øgreid P; Kjellevold KH
Urology; 2003 Jun; 61(6):1266-72. PubMed ID: 12809927
[TBL] [Abstract][Full Text] [Related]
12. Markers of prognosis in superficial bladder cancer.
Fradet Y
Semin Urol; 1992 Feb; 10(1):28-38. PubMed ID: 1565901
[No Abstract] [Full Text] [Related]
13. A hot spot for p53 mutation in transitional cell carcinoma of the bladder: clues to the etiology of bladder cancer.
Xu X; Stower MJ; Reid IN; Garner RC; Burns PA
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):611-6. PubMed ID: 9264274
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of DNA ploidy in bladder cancer treated with preoperative radiation therapy and cystectomy.
Granfors T; Duchek M; Tomic R; Roos G; Ljungberg B
Scand J Urol Nephrol; 1996 Aug; 30(4):281-5. PubMed ID: 8908649
[TBL] [Abstract][Full Text] [Related]
15. Bivariate analysis DNA/cytokeratin 7 and flow cytometric measurement of MIB-1 in superficial transitional carcinoma of the bladder (TCC). Methodological aspects and prognostic implications.
Leonardi E; Cristofori A; Reich A; Dalla Palma P
Eur J Histochem; 1997; 41 Suppl 2():133-4. PubMed ID: 9859817
[No Abstract] [Full Text] [Related]
16. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
[TBL] [Abstract][Full Text] [Related]
17. Chromosome markers and progression in bladder cancer.
Sandberg AA
Cancer Res; 1977 Aug; 37(8 Pt 2):2950-6. PubMed ID: 872125
[No Abstract] [Full Text] [Related]
18. The value of DNA cytometry in transitional cell carcinoma of the urinary bladder.
Nenning H; Rassler J; Minh DH; Stolzenburg JU
Gen Diagn Pathol; 1997 Dec; 143(4):231-6. PubMed ID: 9489956
[TBL] [Abstract][Full Text] [Related]
19. [Studies on bladder cancer using flow cytometry. II. Evaluation of prognosis and intravesical recurrence of bladder cancer based on flow cytometric DNA analysis].
Yoshikawa K; Tochigi T; Hoshi S; Orikasa S; Imai Y
Nihon Hinyokika Gakkai Zasshi; 1987 Feb; 78(2):227-31. PubMed ID: 3613331
[No Abstract] [Full Text] [Related]
20. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
Toyota K
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
